The Effect of Targeted Therapies on Prognostic Factors, Patterns of Care and Survival in Patients with Renal Cell Carcinoma and Brain Metastases

Brain metastases are common in renal cell carcinoma. In the era of targeted therapies, outcomes in patients with renal cell carcinoma (RCC) have improved but it is unknown whether outcomes or prognostic factors for RCC patients with brain metastases have changed. This multi-institutional retrospective review refines prognostic factors for these patients and confirms outcomes for RCC patients with brain metastases have improved. These data will be helpful in clinical decision-making and stratification of clinical trials.

https://ift.tt/2GQCILf